J.C. Penney Company Inc (JCP) 8.52 $JCP The 15 Best S&P

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
J.C. Penney Company Inc (JCP) 8.52 $JCP

The 15 Best S&P 500 Dividend Stocks of Last 25 Years
at The Street - Thu Jul 23, 7:37AM CDT
See the 15 dividend stocks with the best total returns of the last 25 years analyzed in detail.
KSS: 61.87 (-1.00), GD: 144.80 (-0.42), HOG: 58.25 (-0.36), NKE: 114.00 (-0.09), UNH: 119.33 (-1.28), PSA: 201.10 (-0.39), WMT: 72.51 (-0.65), M: 71.21 (-0.70), CB: 122.80 (-0.38), SHLD: 22.08 (+0.12), VNO: 95.89 (-1.05), PAYX: 46.65 (-0.62), DLTR: 78.24 (-0.97), LOW: 67.70 (+0.26), AAPL: 125.16 (-0.06), SCHW: 34.96 (-0.29), ALX: 405.80 (-4.22), HD: 114.59 (-0.31), TROW: 77.28 (-1.46), FDO: 79.39 (+0.04), DDS: 100.39 (-2.32), LEN: 52.46 (-0.73), WBA: 95.48 (-1.16), ADP: 80.94 (-0.75), TJX: 68.24 (-0.37), JCP: 8.52 (-0.21), SHW: 270.48 (-3.21)

Upgrade Alert for JC Penney (JCP)
Comtex SmarTrend(R) - Thu Jul 23, 7:04AM CDT
JC Penney (NYSE:JCP) was upgraded from Neutral to Buy at Buckingham today. The stock closed yesterday at $8.73 on volume of 12.3 million shares, above average daily volume of 10.2 million. JC Penney (NYSE:JCP) is currently priced 2.6% above its average consensus analyst price target of $8.50. The stock should find initial support at its 50-day moving average (MA) of $8.65 and further support at its 200-day MA of $7.96.
JCP: 8.52 (-0.21)

J.C. Penney (JCP) Stock Gains After Analyst Upgrade
at The Street - Wed Jul 22, 11:29AM CDT
J.C. Penney (JCP) shares are higher following an upgrade from Buckingham Research.
JCP: 8.52 (-0.21)

MANDY GINSBERG TO JOIN JCPENNEY BOARD OF DIRECTORS
Thomson Reuters ONE - Tue Jul 21, 4:00PM CDT
PLANO, Texas - (July 21, 2015) - J. C. Penney Company, Inc. (NYSE:JCP) today announced that Mandy Ginsberg, an accomplished leader with extensive online consumer acumen, has been elected to its board of directors. Ginsberg is the chief executive officer of The Princeton Review, a leading test preparation company that helps millions of students get into their dream schools, and Tutor.com, the world's largest internet-based tutoring company that provides live, on-demand learning solutions for students and professionals.
JCP: 8.52 (-0.21)

JCPENNEY RINGS IN THE SCHOOL YEAR WITH TREND-BENDING STYLES TO FIT EVERY KID AND DORM
Thomson Reuters ONE - Tue Jul 21, 7:30AM CDT
Juniors Plus debuts in 200 stores offering teens the most popular looks in more sizes
JCP: 8.52 (-0.21)

Will J. C. Penney Get Boost from Back-to-School Sales? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Jul 20, 5:41PM CDT
J. C. Penney (JCP), similar to other retailers, is gearing up for the back-to-school season, which is regarded as one of the important sales seasons, next only to the Christmas holidays.
NKE: 114.00 (-0.09), TGT: 81.65 (-1.17), JCP: 8.52 (-0.21), M: 71.21 (-0.70)

Apple Targets Back to School - Video Blog
David Bartosiak - Zacks Investment Research - Mon Jul 20, 3:12PM CDT
Apple (AAPL), Target (TGT) and JC Penny (JCP) are all set for back to school deals this week.
AMZN: 482.18 (-6.09), JCP: 8.52 (-0.21), TGT: 81.65 (-1.17), AAPL: 125.16 (-0.06)

JC Penney (JCP) Crosses Pivot Point Support at $8.68
Comtex SmarTrend(R) - Mon Jul 20, 10:21AM CDT
Shares of JC Penney (NYSE:JCP) have bearishly opened below the pivot of $8.82 today and have reached the first support level of $8.68. Analysts will be watching for a cross of the next downside pivot targets of $8.57 and $8.32.
JCP: 8.52 (-0.21)

Is Macy's (M) Contemplating on a REIT Spinoff? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Jul 17, 4:56PM CDT
Will Macy's (M) be the next to spinoff its real estate and related assets to form a real estate investment trust?
KSS: 61.87 (-1.00), JCP: 8.52 (-0.21), M: 71.21 (-0.70), DRI: 74.87 (+0.28)

Next Support Level for JC Penney (JCP) is $8.77
Comtex SmarTrend(R) - Fri Jul 17, 9:37AM CDT
Shares of JC Penney (NYSE:JCP) have bearishly opened below the pivot of $9.02 today and have reached the first support level of $8.86. Analysts will be watching for a cross of the next downside pivot targets of $8.77 and $8.52.
JCP: 8.52 (-0.21)

Companhia Brasileira de Distribuicao Q2 Sales Sluggish - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Jul 16, 3:00PM CDT
Companhia Brasileira de Distribuicao (CBD) has been facing the brunt of a weak economic scenario in Brazil. After reporting sluggish first quarter 2015 results in May, this Brazilian retailer recently posted weak second quarter 2015 sales.
WFM: 41.07 (-0.08), KR: 38.67 (-0.34), JCP: 8.52 (-0.21), CBD: 21.49 (-0.78)

Macy's Gears Up for Back-to-School Season with Top Brands - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Jul 16, 1:55PM CDT
Macy's (M) arms itself with top designers and brands at reasonable prices, to battle tough competition in this back-to-school season.
KSS: 61.87 (-1.00), TGT: 81.65 (-1.17), JCP: 8.52 (-0.21), M: 71.21 (-0.70)

Macy's (M) Worth a Look: Stock Adds 8% in Session - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Jul 16, 8:32AM CDT
Macy's, Inc. (M) was a big mover last session, as the company saw its shares rise nearly 8% on the day.
JCP: 8.52 (-0.21), M: 71.21 (-0.70)

Target Thinks Outside the Big Box
at The Street - Thu Jul 16, 7:00AM CDT
Wal-Mart has also taken great strides, but Target has been more impressive.
KSS: 61.87 (-1.00), JCP: 8.52 (-0.21), TGT: 81.65 (-1.17), CVS: 110.19 (-0.79), WMT: 72.51 (-0.65)

What Macy's Could Be Worth If It Spun Off Its Pricey Real Estate
at The Street - Wed Jul 15, 4:08PM CDT
One notable activist investor thinks the big retailer could be worth significantly more than its current share price if it split into two companies.
JCP: 8.52 (-0.21), M: 71.21 (-0.70), SHLD: 22.08 (+0.12)

Kohl's (KSS) Increases Cash Tender Offer; Announces Pricing - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Jul 15, 12:45PM CDT
Kohl's Corporation (KSS) has increased the maximum combined aggregate principal amount of notes and debentures. In addition, the company has announced pricing of each series of notes and debentures.
WFM: 41.07 (-0.08), KSS: 61.87 (-1.00), KR: 38.67 (-0.34), JCP: 8.52 (-0.21)

Macy's Worth Over 125 Per Share: Starboard's Smith
at Investor's Business Daily - Wed Jul 15, 12:23PM CDT
Macy's (M) shares perked up after Starboard Value's Jeffrey Smith reportedly disclosed that he has taken a position in the department store chain and thinks the stock could be worth over 125 a share, nearly twice its current price. Shares rose 5.8%...
KSS: 61.87 (-1.00), JCP: 8.52 (-0.21), JWN: 78.02 (-0.97), M: 71.21 (-0.70)

JC Penney Has Returned 16.3% Since SmarTrend Recommendation (JCP)
Comtex SmarTrend(R) - Wed Jul 15, 9:54AM CDT
SmarTrend identified an Uptrend for JC Penney (NYSE:JCP) on January 7th, 2015 at $7.76. In approximately 6 months, JC Penney has returned 16.30% as of today's recent price of $9.03.
JCP: 8.52 (-0.21)

Where to Get the Best Deals on Prime Day (Hint: They're Not Just on Amazon)
at The Street - Wed Jul 15, 8:19AM CDT
Amazon isn't the only retailer looking to cash in on Prime Day July 15.
AMZN: 482.18 (-6.09), TGT: 81.65 (-1.17), JCP: 8.52 (-0.21), WMT: 72.51 (-0.65), M: 71.21 (-0.70), BBY: 32.86 (-0.18)

Can Marvin Ellison Save J.C. Penney?
Dan Caplinger, The Motley Fool - Motley Fool - Tue Jul 14, 6:20PM CDT
Big-box discount retail giant J.C. Penney is going into its fifth year of annual losses, with its efforts to make a huge strategic shift in the early 2010s having largely failed. Now that the retailer is trying to recapture lost customers while...
JCP: 8.52 (-0.21)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Updated Category News Views 7

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Continue Reading
LEGO Mashes Star Wars and Marvel for Fans' Delight

Updated Category News Views 7

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Continue Reading
Phase I of 2026 Hong Kong Trade Shows Highlights Innovation

Updated Category News Views 9

Hong Kong Takes Center Stage in Global Commerce Flip through the economic landscape today, and you’ll spot Hong Kong, decked out in its best as a trade linchpin—with over 2,100 suppliers gathered under one roof. AsiaWorld-Expo is buzzing with the commencement of Phase I of the October 2026 Global Sources Hong Kong Shows. The theme's all about 'Connecting Global...

Continue Reading
Southern Company Sparks Swift Power Restoration Post-Isaias

Updated Category News Views 11

Well, when Mother Nature decides to throw a tantrum, it takes seasoned hands and savvy tech to clean up the mess. That's exactly what Southern Company is doing after Hurricane Isaias wreaked havoc on the Southeast. With their electric utilities—Alabama Power, Georgia Power, and Mississippi Power—hitting the ground running, they've already restored power to a whopping...

Continue Reading
AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

Updated Category News Views 5

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Continue Reading
Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

Updated Category News Views 4

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Continue Reading
AI Drives Major Time Savings in Endoscopy Tech

Updated Category News Views 10

AI in Endoscopy: Game-Changer or Gimmick? Stumbling across AnX Robotica's latest pitch about their NaviCam ProScan AI workflow, one can't help but feel a mix of curiosity and skepticism. With the stakes in medical tech sky-high, they've fired off some impressive stats that grab attention. We're talking about cutting small-bowel capsule review times by a whopping...

Continue Reading
2026 Community Impact Week: Slam Dunk for Community Unity

Updated Category News Views 6

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Continue Reading
NARUTO Card Game Set for June 2027 Global Launch

Updated Category News Views 11

Mark Your Calendars: Global Launch June 2027 They're rolling out a red carpet for nostalgia here, I tell ya! At the New York Comic Con, BANDAI announced a worldwide launch for the NARUTO CARD GAME in June 2027. We'll see pre-built decks starring your favorite shinobi and a mad sprint to collect with the new booster packs. Feels sort of like they’re summoning a jutsu...

Continue Reading
Duolingo Faces Lawsuit Over Alleged Investor Missteps

Updated Category News Views 10

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

Continue Reading

Top 5 Most Recently Viewed Articles

Samer Alkhaldi Joins HFM to Drive Business Growth in MENA Region

Updated Category News Views 65

Samer Alkhaldi Takes Charge at HFM for MENA Development In an exciting development for HFM, a prominent player in global online trading, Samer Alkhaldi has been appointed as the new Regional Head of Business Development for the MENA region. With an extensive background in the financial sector, Samer’s appointment is a significant strategy to expand and improve services...

Continue Reading
Kenyan Government's Strategic Shift Towards Digital Operations

Updated Category News Views 286

Kenya's Digital Transformation with Danish F2 Platform The Kenyan government is embarking on an exciting journey towards digital transformation by adopting the Danish F2 platform. This innovative initiative was shared by the Ministry of Information, Communications, and the Digital Economy, aiming to streamline processes across various governmental departments. Objective...

Continue Reading
Brookfield Corporation Plans Upcoming Investor Day Event

Updated Category News Views 210

Brookfield Corporation's Investor Day Announcement Brookfield Corporation (NYSE: BN, TSX: BN) and Brookfield Asset Management Ltd. (NYSE: BAM, TSX: BAM) are gearing up for a significant Investor Day scheduled for a Wednesday in New York. This event aims to engage investors with insights on the company's strategic direction and performance metrics. Event Details The...

Continue Reading
Virtune Updates on MarketVector's Pricing Changes for ETPs

Updated Category News Views 155

Virtune Announces Important Pricing Update for ETPs Virtune, a leading player in digital asset management, has shared significant news regarding its approach to the pricing of its exchange-traded products (ETPs). Effective December 4, 2025, the company will update its reference price provider MarketVector, switching the underlying price source for its crypto assets used...

Continue Reading
Accessible Healthcare Support for Wildfire Affected Residents

Updated Category News Views 157

Virtual Healthcare Appointments for Affected Residents In light of the recent wildfires in Southern California, those who have faced displacement or adversity due to these events can now access more no-cost virtual healthcare appointments. This initiative is expanding to ensure that residents in Los Angeles can receive urgent medical attention, including vital services...

Continue Reading